For the year ending 2025-12-31, VXRT made $237,258K in revenue. $16,320K in net income. Net profit margin of 6.88%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenues | 237,258 | |||
| Research and development | 201,576 | |||
| General and administrative | 17,608 | |||
| Total operating expenses | 219,184 | |||
| Operating income (loss) | 18,074 | |||
| Interest income | 1,596 | |||
| Non-cash interest expense related to sale of future royalties | 2,823 | |||
| Other income (expense), net | -44 | |||
| Income (loss) before income taxes | 16,803 | |||
| Provision for income taxes | 476 | |||
| Net income (loss) | 16,327 | |||
| Unrealized gain (loss) on available-for-sale investments, net of tax | -7 | |||
| Comprehensive income (loss) | 16,320 | |||
| Basic EPS | 0.07 | |||
| Diluted EPS | 0.07 | |||
| Basic Average Shares | 230,269,605 | |||
| Diluted Average Shares | 230,346,201 | |||
Vaxart, Inc. (VXRT)
Vaxart, Inc. (VXRT)